1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow ingenol mebutate: new trials by email Literature Review of ingenol mebutate trials Research Report on ingenol mebutate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of Ingenol Mebutate Gel 0.06% When Applied Once Daily for 2, 3 or 4 Consecutive Days to a Treatment Area of Approximately 250 cm2 on Trunk and Extremities in Subjects With Actinic Keratosis ingenol mebutate, Placebo - Actinic Keratosis | Phase 2 | Completed | LEO Pharma | 266 | 2014-01-01 | 2025-03-10 |
LEO Pharma (1)
United States (1)